Sermorelin

Overview

Sermorelin (GRF 1-29) is a synthetic peptide fragment of growth-hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the native sequence. It is examined exclusively in preclinical and in vitro laboratory research for its role in pituitary signaling and growth-hormone regulatory pathways. Studies focus on the molecular and cellular mechanisms by which Sermorelin interacts with GHRH receptors and modulates intracellular signaling under controlled, non-clinical experimental conditions.

Specifications

• Unit Size: 10 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

Laboratory and preclinical studies have explored Sermorelin in relation to:

• Pituitary receptor binding and growth-hormone secretagogue signaling

• Regulation of GH and IGF-1 pathways in cellular and animal models

• Investigation of short-acting peptide kinetics in bio-signaling research

• Studies on hypothalamic-pituitary axis regulation in experimental conditions

All findings originate from controlled laboratory studies and are not indicative of any safety or efficacy profile for clinical or veterinary use.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Buyer must be a qualified researcher or institution and assumes all responsibility for compliance with applicable regulations and safe handling.

Important Notice

This product is intended strictly for scientific and educational research. No claims are made regarding therapeutic, diagnostic, or preventive effects. The seller does not warrant the product’s suitability for human or animal administration. All handling and disposal must comply with institutional biosafety standards.